Rule 26 Disclosures

The following information is disclosed in accordance with Rule 26 of the AIM and Euronext Growth Rules for Companies.

Country of Incorporation

Ovoca Bio plc is incorporated in Ireland. The Company is an AIM-quoted and Euronext Growth-quoted Pharmaceuticals & Biotechnology Company.

As the Company is an Irish company and is subject to the Irish Companies Acts, the rights of shareholders may be different to the rights of shareholders in a UK incorporated company.

Capital Structure

The capital of the Company is made up of Ordinary Shares. The authorised share capital of the Company is 120,000,000 Ordinary Shares of €0.125 each, of which 81,563,806 Ordinary Shares (excluding Treasury Shares) and 6,895,000 Treasury Shares were in issue as at 10/05/2023.

The percentage of shares not in public hands is approximately 52.5%.

The table below sets out the interests of other shareholders who have made significant shareholder disclosures to the Company indicating holding of 3 percent or more as at 22/01/2024:

Shareholder No. of €0.125 Ordinary Shares % of Issued Share Capital (excl. Treasury Shares)
Kirill Golovanov 19,506,203 23.92%
Leonid Skoptsov 10,002,078 12.26%
Yuri Radchenko 10,002,077 12.26%

So far as the Company is aware, the names of persons who, directly or indirectly, are interested in 3 percent or more of the issued share capital of the Company as at 22/01/2024 are as follows:

Shareholder No. of €0.125 Ordinary Shares % of Issued Share Capital (excl. Treasury Shares)
Euroclear Nominees Limited 54,053,193 61.11%
Picko Trading Co Limited 7,928,531 8.96%

There are no restrictions on the transfer of the shares of the Company. Ovoca is subject to the Irish Takeover Panel Act 1997, Takeover Rules 2022 (“Takeover Rules”)

Financial Reports

Annual reports and half yearly reports of Ovoca can be found here.

Regulatory Notifications

For a list of regulatory notifications and shareholder circulars published by Ovoca click here.


For details of the Board of Directors of Ovoca click here.

Board Committees

There are three Committees of the Board of Directors. For detailed information please click here.

Corporate Governance

Please click here for details of our Corporate Governance.


For details of Ovoca’s nominated adviser and other advisers to the Company click here.

Memorandum & Articles

To view the Company’s Memorandum and Articles click here.

Admission Documents/Recent Circulars

To view the Company’s Admission Document click here.
To view the Company’s Re-Admission Document for the Proposed Acquisition of IVIX use this link.
To view the Company’s most recent EGM-related Circular concerning share migration click here.